Literature DB >> 16960890

Long-term effects of tumor necrosis factor-alpha treatment on insulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt/PKB.

Dhananjay Gupta1, Shailly Varma, Ramji L Khandelwal.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) mediated attenuation of insulin signaling pathway is an important cause in several disorders like obesity, obesity linked diabetes mellitus. TNF-alpha actions vary depending upon concentration and time of exposure in various cells. In the present study, the effects of long-term TNF-alpha (1 ng/ml) exposure on the components of insulin signaling pathway in HepG2 and HepG2 cells overexpressing constitutively active Akt1/PKB-alpha (HepG2-CA-Akt/PKB) have been investigated. In parental HepG2 cells, TNF-alpha treatment for 24 h reduced the phosphorylation of Akt1/PKB-alpha and GSK-3beta and under these conditions cells also showed reduced insulin responsiveness in terms of Akt1/PKB-alpha and GSK-3beta phosphorylation. TNF-alpha pre-incubated HepG2-CA-Akt/PKB cells showed lower reduction in Akt1/PKB-alpha and GSK-3beta phosphorylation and insulin responsiveness after 24 h as compared to parental HepG2 cells. We report that the long-term TNF-alpha pre-incubation in both parental HepG2 and HepG2-CA-Akt/PKB-alpha cells leads to the reduction in the levels of IRS-1 without altering the levels of IRS-2. In order to understand the reason for the differential insulin resistance in both the cell types, the effect of long-term TNF-alpha treatment on the proteins upstream to Akt/PKB was investigated. TNF-alpha pre-incubation also showed reduced insulin-stimulated Tyr phosphorylation of insulin receptor (IR-beta) in both the cell types, moreover hyperphosphorylation of IRS-1 at Ser 312 residue was observed in TNF-alpha pre-incubated cells. As hyperphosphorylation of IRS-1 at Ser 312 can induce its degradation, it is possible that reduced insulin responsiveness after long-term TNF-alpha pre-incubation observed in this study is due to the decrease in IRS-1 levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16960890     DOI: 10.1002/jcb.21080

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Association between new markers of cardiovascular risk and hepatic insulin resistance in those at high risk of developing type 2 diabetes.

Authors:  Lucilla D Monti; Camillo Bechi Genzano; Barbara Fontana; Elena Galluccio; Serena Spadoni; Andrea Magistro; Emanuele Bosi; Piermarco Piatti
Journal:  Endocrine       Date:  2021-09-21       Impact factor: 3.633

2.  Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction.

Authors:  Cyrus V Desouza; Frederick G Hamel; Keshore Bidasee; Kelly O'Connell
Journal:  Diabetes       Date:  2011-02-23       Impact factor: 9.461

Review 3.  New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.

Authors:  Di Yan; Andrew Blauvelt; Amit K Dey; Rachel S Golpanian; Samuel T Hwang; Nehal N Mehta; Bridget Myers; Zhen-Rui Shi; Gil Yosipovitch; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-04-19       Impact factor: 7.590

4.  siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.

Authors:  Reginald L Austin; Anna Rune; Karim Bouzakri; Juleen R Zierath; Anna Krook
Journal:  Diabetes       Date:  2008-04-28       Impact factor: 9.461

5.  Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.

Authors:  Massimo Collino; Manuela Aragno; Sara Castiglia; Chiara Tomasinelli; Christoph Thiemermann; Giuseppe Boccuzzi; Roberto Fantozzi
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

Review 6.  Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications.

Authors:  Prodromos I Sidiropoulos; Stylianos A Karvounaris; Dimitrios T Boumpas
Journal:  Arthritis Res Ther       Date:  2008-05-08       Impact factor: 5.156

7.  Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis.

Authors:  Min Kyoung Kang; Byeong Hun Kang; Jong Ho Kim
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

8.  Protein phosphatase 4 (PP4) functions as a critical regulator in tumor necrosis factor (TNF)-α-induced hepatic insulin resistance.

Authors:  Hongye Zhao; Xiuqing Huang; Juan Jiao; Hangxiang Zhang; Jin Liu; Weiwei Qin; Xiangyu Meng; Tao Shen; Yajun Lin; Jiaojiao Chu; Jian Li
Journal:  Sci Rep       Date:  2015-12-15       Impact factor: 4.379

Review 9.  Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review.

Authors:  Giacomo Dal Bello; Paolo Gisondi; Luca Idolazzi; Giampiero Girolomoni
Journal:  Rheumatol Ther       Date:  2020-04-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.